|
GSR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.182600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.401420E-03 |
| Normal-vs-Stage2 |
1.560810E-01 |
| Normal-vs-Stage3 |
8.479800E-01 |
| Normal-vs-Stage4 |
8.618200E-01 |
| Stage1-vs-Stage2 |
5.589600E-01 |
| Stage1-vs-Stage3 |
8.490000E-02 |
| Stage1-vs-Stage4 |
2.396600E-01 |
| Stage2-vs-Stage3 |
3.149800E-01 |
| Stage2-vs-Stage4 |
3.163800E-01 |
| Stage3-vs-Stage4 |
9.989600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.017100E-03 |
| Normal-vs-AfricanAmerican |
7.440000E-03 |
| Normal-vs-Asian |
4.136600E-01 |
| Caucasian-vs-AfricanAmerican |
9.164400E-01 |
| Caucasian-vs-Asian |
9.926600E-01 |
| AfricanAmerican-vs-Asian |
9.585600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14570000000025E-05 |
| Normal-vs-Female |
5.175800E-01 |
| Male-vs-Female |
2.810200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.049200E-01 |
| Normal-vs-Extreme_Weight |
1.54829999932105E-08 |
| Normal-vs-Obese |
4.954200E-01 |
| Normal-vs-Extreme_Obese |
6.484400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.478000E-02 |
| Normal_Weight-vs-Obese |
9.342800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.582400E-01 |
| Extreme_Weight-vs-Obese |
4.712200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.330000E-01 |
| Obese-vs-Extreme_Obese |
9.016000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.055400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.412800E-04 |
| Normal-vs-Age(61-80Yrs) |
8.539400E-03 |
| Normal-vs-Age(81-100Yrs) |
7.973900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.268600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.257200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.536200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.697600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.584600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.716800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.99830041403004E-10 |
| Normal-VS-Type2 PRCC |
4.208000E-01 |
| Normal-VS-KIRP CIMP |
1.441960E-01 |
| Normal-VS-Unclassified PRCC |
7.77290000000264E-05 |
| Type1 PRCC-VS-Type2 PRCC |
6.624700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.36149999999213E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
1.326820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.283400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.142700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.147780E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.269810E-02 |
| Normal-vs-N1 |
6.749200E-01 |
| Normal-vs-N2 |
4.423800E-01 |
| N0-vs-N1 |
1.771790E-01 |
| N0-vs-N2 |
2.844400E-01 |
| N1-vs-N2 |
5.229600E-01 |
|
|
